Bonfils P, Luciani J A, Potard G, Bassot V
Service d'ORL et de Chirurgie Cervico-Faciale, Faculté Necker-Enfants Malades, Université René Descartes, Hôpital Boucicaut, Paris.
Ann Otolaryngol Chir Cervicofac. 1996;113(7-8):425-9.
Seventy-eight consecutive patients treated by chemotherapy for ENT cancers and having a subclavian catheter for venous access were studied prospectively to assess the prevalence of venous thrombosis. Thrombosis of the subclavian vein was demonstrated clinically in 4 patients and by ultrasonography in 7 patients. The prevalence of thrombosis was 14.1%. No clinical or biological predisposition factor could be identified. Subclavian thrombosis mostly occurred during the second month after implantation (91% of cases). Ultrasonography seems the most useful non-invasive technique for the diagnosis of subclavian thrombosis.
对78例接受化疗的耳鼻喉科癌症患者进行了前瞻性研究,这些患者均通过锁骨下静脉置管建立静脉通路,以评估静脉血栓形成的发生率。4例患者临床诊断为锁骨下静脉血栓形成,7例患者经超声检查确诊。血栓形成的发生率为14.1%。未发现临床或生物学易患因素。锁骨下静脉血栓形成大多发生在置管后的第二个月(91%的病例)。超声检查似乎是诊断锁骨下静脉血栓形成最有用的非侵入性技术。